Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06206252 · ClinicalTrials.gov registry record

Can Medical Cannabis Affect Opioid Use?

A clinical trial of Pain and Chronic Pain, sponsored by Thomas Jefferson University.

Recruiting
Registry status
110
Enrollment target
1
Study location

NCT06206252 is a study of Pain and Chronic Pain that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 110 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06206252, a study of Pain and Chronic Pain, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
110 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn how medical cannabis (MC) affects pain and the use of opioid pain medications. Participants who have chronic pain and use prescribed opioid pain medication will opt-in to using MC or not for the 3-month study. Participants who are certified in Pennsylvania will purchase specific medical cannabis products at a reduced cost from a partnering medical cannabis dispensary monthly. All participants will complete baseline, daily, and monthly assessments to observe changes across groups.

Conditions Studied

Interventions

  • OTHER Medical Cannabis

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-09-07
Est. Completion 2026-01

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT06206252

The ClinicalTrials.gov registry entry for NCT06206252 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Medical Cannabis is the first listed.

NCT06206252 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06206252 about?

NCT06206252 is a clinical study titled "Can Medical Cannabis Affect Opioid Use?". The goal of this observational study is to learn how medical cannabis (MC) affects pain and the use of opioid pain medications. Participants who have chronic pain and use prescribed opioid pain medication will opt-in to using MC or not for the 3-month study. Participants who are certified in Pennsyl...

What is the current status of trial NCT06206252?

This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2023-09-07. Estimated completion is 2026-01.

What conditions does trial NCT06206252 study?

This clinical trial studies the following conditions: Pain, Chronic Pain.

What interventions are being tested in trial NCT06206252?

The interventions under investigation include: Medical Cannabis (OTHER).

Who is sponsoring clinical trial NCT06206252?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06206252 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.